Cargando…
Prognostic role of neutrophil–lymphocyte ratio in esophageal cancer: A systematic review and meta-analysis
BACKGROUND: The prognostic role of neutrophil-to-lymphocyte ratio (NLR) in esophageal cancer (EC) remains controversial. METHODS: The aim of this study was to evaluate the association between NLR and oncologic outcome of EC patients through a meta-analysis. A systematic search was performed in PubMe...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310576/ https://www.ncbi.nlm.nih.gov/pubmed/30544482 http://dx.doi.org/10.1097/MD.0000000000013585 |
_version_ | 1783383464688484352 |
---|---|
author | Zhang, Xiangwei Jiang, Yuanzhu Wang, Yang Wang, Zhaoyang Zhao, Linping Xue, Xianbiao Sang, Shaowei Zhang, Lin |
author_facet | Zhang, Xiangwei Jiang, Yuanzhu Wang, Yang Wang, Zhaoyang Zhao, Linping Xue, Xianbiao Sang, Shaowei Zhang, Lin |
author_sort | Zhang, Xiangwei |
collection | PubMed |
description | BACKGROUND: The prognostic role of neutrophil-to-lymphocyte ratio (NLR) in esophageal cancer (EC) remains controversial. METHODS: The aim of this study was to evaluate the association between NLR and oncologic outcome of EC patients through a meta-analysis. A systematic search was performed in PubMed, Web of Science and Embase for relevant studies. Meta-analysis was performed using hazard ratio (HR) and95% confidence interval (CI) as effect measures. RESULTS: Finally, 33 articles with 11,039patients were included in our study. The synthesized results indicated that the elevated NLR was negatively related to overall survival (OS) (HR = 1.39, 95% CI: 1.23–1.54). When the patients were stratified according to country, pathological type, treatment strategies, sample size, and different HR estimate method, high NLR was also significantly correlated with poor OS. Similarly, elevated NLR was also associated with shorter disease-free survival (DFS), progress-free survival (PFS), relapse-free survival (RFS), and cancer-specific survival (CSS). CONCLUSION: The elevated pretreatment NLR is associated with poor oncological outcomes in patients with EC. NLR may be a significant predictive biomarker in EC. Further large-cohort studies are needed to confirm these findings. |
format | Online Article Text |
id | pubmed-6310576 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-63105762019-01-14 Prognostic role of neutrophil–lymphocyte ratio in esophageal cancer: A systematic review and meta-analysis Zhang, Xiangwei Jiang, Yuanzhu Wang, Yang Wang, Zhaoyang Zhao, Linping Xue, Xianbiao Sang, Shaowei Zhang, Lin Medicine (Baltimore) Research Article BACKGROUND: The prognostic role of neutrophil-to-lymphocyte ratio (NLR) in esophageal cancer (EC) remains controversial. METHODS: The aim of this study was to evaluate the association between NLR and oncologic outcome of EC patients through a meta-analysis. A systematic search was performed in PubMed, Web of Science and Embase for relevant studies. Meta-analysis was performed using hazard ratio (HR) and95% confidence interval (CI) as effect measures. RESULTS: Finally, 33 articles with 11,039patients were included in our study. The synthesized results indicated that the elevated NLR was negatively related to overall survival (OS) (HR = 1.39, 95% CI: 1.23–1.54). When the patients were stratified according to country, pathological type, treatment strategies, sample size, and different HR estimate method, high NLR was also significantly correlated with poor OS. Similarly, elevated NLR was also associated with shorter disease-free survival (DFS), progress-free survival (PFS), relapse-free survival (RFS), and cancer-specific survival (CSS). CONCLUSION: The elevated pretreatment NLR is associated with poor oncological outcomes in patients with EC. NLR may be a significant predictive biomarker in EC. Further large-cohort studies are needed to confirm these findings. Wolters Kluwer Health 2018-12-10 /pmc/articles/PMC6310576/ /pubmed/30544482 http://dx.doi.org/10.1097/MD.0000000000013585 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | Research Article Zhang, Xiangwei Jiang, Yuanzhu Wang, Yang Wang, Zhaoyang Zhao, Linping Xue, Xianbiao Sang, Shaowei Zhang, Lin Prognostic role of neutrophil–lymphocyte ratio in esophageal cancer: A systematic review and meta-analysis |
title | Prognostic role of neutrophil–lymphocyte ratio in esophageal cancer: A systematic review and meta-analysis |
title_full | Prognostic role of neutrophil–lymphocyte ratio in esophageal cancer: A systematic review and meta-analysis |
title_fullStr | Prognostic role of neutrophil–lymphocyte ratio in esophageal cancer: A systematic review and meta-analysis |
title_full_unstemmed | Prognostic role of neutrophil–lymphocyte ratio in esophageal cancer: A systematic review and meta-analysis |
title_short | Prognostic role of neutrophil–lymphocyte ratio in esophageal cancer: A systematic review and meta-analysis |
title_sort | prognostic role of neutrophil–lymphocyte ratio in esophageal cancer: a systematic review and meta-analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310576/ https://www.ncbi.nlm.nih.gov/pubmed/30544482 http://dx.doi.org/10.1097/MD.0000000000013585 |
work_keys_str_mv | AT zhangxiangwei prognosticroleofneutrophillymphocyteratioinesophagealcancerasystematicreviewandmetaanalysis AT jiangyuanzhu prognosticroleofneutrophillymphocyteratioinesophagealcancerasystematicreviewandmetaanalysis AT wangyang prognosticroleofneutrophillymphocyteratioinesophagealcancerasystematicreviewandmetaanalysis AT wangzhaoyang prognosticroleofneutrophillymphocyteratioinesophagealcancerasystematicreviewandmetaanalysis AT zhaolinping prognosticroleofneutrophillymphocyteratioinesophagealcancerasystematicreviewandmetaanalysis AT xuexianbiao prognosticroleofneutrophillymphocyteratioinesophagealcancerasystematicreviewandmetaanalysis AT sangshaowei prognosticroleofneutrophillymphocyteratioinesophagealcancerasystematicreviewandmetaanalysis AT zhanglin prognosticroleofneutrophillymphocyteratioinesophagealcancerasystematicreviewandmetaanalysis |